Photo of: Amber Salzman

Dr. Amber Salzman

View Title...

Cardiokine , Inc.
Philadelphia, Pennsylvania
Amber's profile was created using:
Sort By:

1-10 of 31 online sources for Amber Salzman

  • View Online Source
    www.ddw-online.com/industrynews/277808/url=/editorial_b - [Cached Version]
    Published on: 9/29/2009    Last Visited: 9/29/2009  

    Dr Amber Salzman Dr. Amber Salzman currently serves as Senior Vice-President of R&D Information Technology at GlaxoSmithKline. In this role, Amber leads a transnational organization responsible for exploiting the expanding capabilities of information technology and knowledge management into pharmaceutical research and development, and ensuring efficient and effective use of technologies to drive productivity. During her 20 years with GlaxoSmithKline Pharmaceuticals Research & Development and legacy companies, Amber has established innovative management processes to support a transnational organization, optimized key business processes, and delivered critical business applications, and established an effective global computing environment. Amber has combined senior leadership and strategic capabilities along with consistent execution and delivery on a worldwide basis during her career at GSK. She has held increasingly senior leadership positions demonstrating creativity and analytical skills in improving the organization's effectiveness in accomplishing goals, and delivered essential strategies to evolve GlaxoSmithKline's use of technologies and related sciences. In addition to her role at GlaxoSmithKline, Amber leads a Medical Research Foundation taking an entrepreneurial approach to finding better therapies for people with Adrenoleukodystrophy leveraging innovative technologies such as stem cells and gene therapy. Prior to joining GSK, Amber worked at the Medical College of Pennsylvania. She holds a PhD in Mathematics from Bryn Mawr College and BA in Computer Science from Temple University.

  • View Online Source
    pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oc - [Cached Version]
    Published on: 10/12/2009    Last Visited: 10/15/2009  

    Cardiokine (Philadelphia, PA), a specialty pharmaceutical company, named Amber Salzman president, CEO, and a member of the board of directors. Salzman previously was a member of the research and development executive team at GlaxoSmithKline (London).

  • View Online Source
    ddw.trafika.co.uk/cgi-bin/articles.pl?section=55&id=885 - [Cached Version]
    Published on: 7/31/2007    Last Visited: 7/31/2007  

    Dr Amber Salzman, Snr VP R&D IT, GSKDrug Discovery World
    ...
    Dr Amber Salzman, Snr VP R&D IT, GSK

  • View Online Source
    www.zeenews.com/articles.asp?aid=363490&ssid=54&sid=BUS - [Cached Version]
    Published on: 4/2/2007    Last Visited: 4/2/2007  

    Amber Salzman, senior vice-president of development operations at GSK, said in a statement that the company had picked TCS as a partner because of its strong record in knowledge process outsourcing and operational excellence.

  • View Online Source
    philadelphia.ujcfedweb.org/page.html?ArticleID=159356 - [Cached Version]
    Published on: 12/5/2007    Last Visited: 1/18/2008  

    Some 100 young professionals gathered to hear Dr. Amber Salzman, Senior Vice President of Worldwide Development Operations at GlaxoSmithKline, speak about her personal and professional path, network and learn about our community.

  • View Online Source
    www.ddw-online.com/informatics/302284/url=/testimonials - [Cached Version]
    Published on: 5/19/2006    Last Visited: 9/29/2009  

    Dr Amber Salzman, Snr VP Development Operations, GSK

  • View Online Source
    www.jewishphilly.org/page.html?ArticleID=94278 - [Cached Version]
    Published on: 10/24/2007    Last Visited: 10/24/2007  

    Come and meet Dr. Amber Salzman, Senior Vice President, Worldwide Development Operations, GlaxoSmithKline on November 15, 2007.Find out more...

  • View Online Source
    www.redhotcurry.com/archive/business/2007/gsk_tcs.htm - [Cached Version]
    Published on: 4/2/2007    Last Visited: 2/1/2008  

    Amber Salzman, senior vice-president of development operations at GSK, said in a statement that the company had picked TCS as a partner because of its strong record in knowledge process outsourcing and operational excellence.

  • View Online Source
    www.deccan.com/Business/Business.asp?#ADB%20critical%20 - [Cached Version]
    Published on: 3/27/2007    Last Visited: 3/27/2007  

    "This strategic partnership with TCS represents a significant step towards GSK's vision of leveraging key talent globally to develop innovative medicines," said Dr Amber Salzman, senior vice president, development operations, GSK."GSK has chosen to partner with TCS because of its strong record in knowledge process outsourcing, underpinned by operational excellence," she said.

  • View Online Source
    ddw.trafika.co.uk/cgi-bin/articles.pl?section=55&id=885 - [Cached Version]
    Published on: 12/5/2007    Last Visited: 12/5/2007  

    Dr Amber Salzman, Snr VP R&D IT,Drug Discovery World
    ...
    Dr Amber Salzman, Snr VP R&D IT,

Page:  1 2 3 4 Next

Wrong Person?

Try these instead
Related searches
More...

Copyright © 2009 Zoom Information Inc. All rights reserved.

BBeachHead-2009-11-09_RC001.1 OM11